Ginwa Enterprise Group Inc (SHG:600080) — Market Cap & Net Worth
Market Cap & Net Worth: Ginwa Enterprise Group Inc (600080)
Ginwa Enterprise Group Inc (SHG:600080) has a market capitalization of $251.80 Million (CN¥1.72 Billion) as of June 22, 2026. Listed on the SHG stock exchange, this China-based company holds position #15696 globally and #4580 in its home market, demonstrating a -6.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ginwa Enterprise Group Inc's stock price CN¥4.61 by its total outstanding shares 373270285 (373.27 Million). Review Ginwa Enterprise Group Inc (600080) total liabilities to assess the company's total debt and financial obligations.
Ginwa Enterprise Group Inc Market Cap History: 2015 to 2026
Ginwa Enterprise Group Inc's market capitalization history from 2015 to 2026. Data shows change from $759.19 Million to $251.80 Million (-6.74% CAGR).
Ginwa Enterprise Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ginwa Enterprise Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.76x
Ginwa Enterprise Group Inc's market cap is 0.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
26.44x
Ginwa Enterprise Group Inc's market cap is 26.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $665.41 Million | $666.65 Million | $27.30 Million | 1.00x | 24.37x |
| 2017 | $434.01 Million | $757.18 Million | $53.46 Million | 0.57x | 8.12x |
| 2018 | $381.57 Million | $745.16 Million | $38.32 Million | 0.51x | 9.96x |
| 2019 | $323.33 Million | $754.54 Million | $25.90 Million | 0.43x | 12.48x |
| 2020 | $301.46 Million | $668.18 Million | $37.74 Million | 0.45x | 7.99x |
| 2021 | $465.92 Million | $534.04 Million | -$18.16 Million | 0.87x | N/A |
| 2022 | $426.59 Million | $579.37 Million | $33.46 Million | 0.74x | 12.75x |
| 2023 | $406.93 Million | $565.40 Million | -$42.89 Million | 0.72x | N/A |
| 2024 | $426.59 Million | $585.46 Million | $74.61 Million | 0.73x | 5.72x |
| 2025 | $411.84 Million | $544.04 Million | $15.58 Million | 0.76x | 26.44x |
Competitor Companies of 600080 by Market Capitalization
Companies near Ginwa Enterprise Group Inc in the global market cap rankings as of June 22, 2026.
Key companies related to Ginwa Enterprise Group Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #554 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #602 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #554 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #602 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.50 |
Ginwa Enterprise Group Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Ginwa Enterprise Group Inc's market cap moved from $759.19 Million to $ 251.80 Million, with a yearly change of -6.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥251.80 Million | -38.86% |
| 2025 | CN¥411.84 Million | -3.46% |
| 2024 | CN¥426.59 Million | +4.83% |
| 2023 | CN¥406.93 Million | -4.61% |
| 2022 | CN¥426.59 Million | -8.44% |
| 2021 | CN¥465.92 Million | +54.55% |
| 2020 | CN¥301.46 Million | -6.76% |
| 2019 | CN¥323.33 Million | -15.26% |
| 2018 | CN¥381.57 Million | -12.08% |
| 2017 | CN¥434.01 Million | -34.78% |
| 2016 | CN¥665.41 Million | -12.35% |
| 2015 | CN¥759.19 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Ginwa Enterprise Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $251.80 Million USD |
| MoneyControl | $251.80 Million USD |
| MarketWatch | $251.80 Million USD |
| marketcap.company | $251.80 Million USD |
| Reuters | $251.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ginwa Enterprise Group Inc
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more